Tonix Pharmaceuticals Holding Corp. (TNXP) is a publicly traded Healthcare sector company. As of May 21, 2026, TNXP trades at $14.21 with a market cap of $227.32M and a P/E ratio of -0.99. TNXP moved +5.47% today. Year to date, TNXP is -4.73%; over the trailing twelve months it is -51.51%. Its 52-week range spans $6.76 to $130.00. Analyst consensus is strong buy with an average price target of $41.33. Rallies surfaces TNXP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns TNXP stock?
Hedge funds tracked by Rallies that own TNXP include Davidson Kempner. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tonix Pharmaceuticals Holding Corp..
TNXP Key Metrics
Key financial metrics for TNXP
Metric
Value
Price
$14.21
Market Cap
$227.32M
P/E Ratio
-0.99
EPS
$-14.53
Dividend Yield
0.00%
52-Week High
$130.00
52-Week Low
$6.76
Volume
339
Avg Volume
0
Revenue (TTM)
$17.56M
Net Income
$-147.39M
Gross Margin
58.56%
Top Hedge Funds Holding TNXP
Davidson Kempner holds 90.01K shares of TNXP, changed +0.00% as of Dec 31, 2025.
Hedge funds tracked by Rallies that own TNXP include Davidson Kempner. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tonix Pharmaceuticals Holding Corp..
Does Rallies show 13F holders for TNXP?
Yes. Rallies tracks hedge fund and 13F ownership data for TNXP, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TNXP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TNXP. It does not provide personalized investment advice.
